Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study

<p>Abstract</p> <p>Background</p> <p>Lack of treatment initiation or intensification might explain why some patients with type 2 diabetes do not reach target goals. The objective is to assess trends in risk factor treatment, and identify determinants for medication adju...

Full description

Bibliographic Details
Main Authors: Bilo Henk JG, de Zeeuw Dick, Denig Petra, Greving Jacoba P, Haaijer-Ruskamp Flora M
Format: Article
Language:English
Published: BMC 2007-09-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/6/1/25
_version_ 1818757248316342272
author Bilo Henk JG
de Zeeuw Dick
Denig Petra
Greving Jacoba P
Haaijer-Ruskamp Flora M
author_facet Bilo Henk JG
de Zeeuw Dick
Denig Petra
Greving Jacoba P
Haaijer-Ruskamp Flora M
author_sort Bilo Henk JG
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Lack of treatment initiation or intensification might explain why some patients with type 2 diabetes do not reach target goals. The objective is to assess trends in risk factor treatment, and identify determinants for medication adjustments in patients with uncontrolled hypertension and/or hyperlipidemia.</p> <p>Methods</p> <p>We conducted a cohort study using data from the Zwolle Outpatient Diabetes project Integrated Available Care (ZODIAC)-study in The Netherlands. Management of hypertension and hyperlipidemia was assessed yearly from 1998–2004 by measuring the percentage of patients receiving a treatment initiation or intensification among all patients with elevated risk factor levels. Generalized estimating equation analyses were performed.</p> <p>Results</p> <p>During the study period, the percentage of patients with an elevated total cholesterol/high-density lipoproteins ratio (>6) decreased considerably (from 29% to 4%) whereas the percentage of hypertensive patients decreased only slightly (≥ 150/85 mmHg; from 58% to 51%). Initiation of lipid-lowering therapy and intensification of antihypertensive therapy was higher in more recent years. However, still two-third of patients with insufficiently controlled blood pressure in 2003 did not receive an initiation or intensification of antihypertensive treatment in the following year. Treatment changes were mainly determined by elevated levels of the corresponding risk factor. We did not observe increased initiation rates for lipid-lowering therapy in patients with both hypertension and hyperlipidemia.</p> <p>Conclusion</p> <p>Hypertension and hyperlipidemia management in type 2 diabetes patients has improved in the past decade but further improvement is possible. Greater effort is needed to stimulate medication adjustments in patients with insufficiently controlled hypertension and combined risk factors.</p>
first_indexed 2024-12-18T06:07:55Z
format Article
id doaj.art-42deb3aae1ea4d86b54bb36429fea66a
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-12-18T06:07:55Z
publishDate 2007-09-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-42deb3aae1ea4d86b54bb36429fea66a2022-12-21T21:18:29ZengBMCCardiovascular Diabetology1475-28402007-09-01612510.1186/1475-2840-6-25Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational studyBilo Henk JGde Zeeuw DickDenig PetraGreving Jacoba PHaaijer-Ruskamp Flora M<p>Abstract</p> <p>Background</p> <p>Lack of treatment initiation or intensification might explain why some patients with type 2 diabetes do not reach target goals. The objective is to assess trends in risk factor treatment, and identify determinants for medication adjustments in patients with uncontrolled hypertension and/or hyperlipidemia.</p> <p>Methods</p> <p>We conducted a cohort study using data from the Zwolle Outpatient Diabetes project Integrated Available Care (ZODIAC)-study in The Netherlands. Management of hypertension and hyperlipidemia was assessed yearly from 1998–2004 by measuring the percentage of patients receiving a treatment initiation or intensification among all patients with elevated risk factor levels. Generalized estimating equation analyses were performed.</p> <p>Results</p> <p>During the study period, the percentage of patients with an elevated total cholesterol/high-density lipoproteins ratio (>6) decreased considerably (from 29% to 4%) whereas the percentage of hypertensive patients decreased only slightly (≥ 150/85 mmHg; from 58% to 51%). Initiation of lipid-lowering therapy and intensification of antihypertensive therapy was higher in more recent years. However, still two-third of patients with insufficiently controlled blood pressure in 2003 did not receive an initiation or intensification of antihypertensive treatment in the following year. Treatment changes were mainly determined by elevated levels of the corresponding risk factor. We did not observe increased initiation rates for lipid-lowering therapy in patients with both hypertension and hyperlipidemia.</p> <p>Conclusion</p> <p>Hypertension and hyperlipidemia management in type 2 diabetes patients has improved in the past decade but further improvement is possible. Greater effort is needed to stimulate medication adjustments in patients with insufficiently controlled hypertension and combined risk factors.</p>http://www.cardiab.com/content/6/1/25
spellingShingle Bilo Henk JG
de Zeeuw Dick
Denig Petra
Greving Jacoba P
Haaijer-Ruskamp Flora M
Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
Cardiovascular Diabetology
title Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
title_full Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
title_fullStr Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
title_full_unstemmed Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
title_short Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study
title_sort trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998 2004 a longitudinal observational study
url http://www.cardiab.com/content/6/1/25
work_keys_str_mv AT bilohenkjg trendsinhyperlipidemiaandhypertensionmanagementintype2diabetespatientsfrom19982004alongitudinalobservationalstudy
AT dezeeuwdick trendsinhyperlipidemiaandhypertensionmanagementintype2diabetespatientsfrom19982004alongitudinalobservationalstudy
AT denigpetra trendsinhyperlipidemiaandhypertensionmanagementintype2diabetespatientsfrom19982004alongitudinalobservationalstudy
AT grevingjacobap trendsinhyperlipidemiaandhypertensionmanagementintype2diabetespatientsfrom19982004alongitudinalobservationalstudy
AT haaijerruskampfloram trendsinhyperlipidemiaandhypertensionmanagementintype2diabetespatientsfrom19982004alongitudinalobservationalstudy